Miyoung Chun

Dr. Miyoung Chun is the executive director of MIT’s Alzheimer’s Innovation Hub and co-founder of Alzheimer’s X, and an advisor to QLS. Prior to her current positions, she has served in leadership roles in higher education, the biotechnology industry, and philanthropy. As a professor of biochemistry at Boston University School of Medicine, she conducted research in and taught cell biology and molecular medicine. As a scientist at Millennium Pharmaceuticals (now Takeda Oncology), her functional genomics and molecular imaging research led to 33 patents. From 2007 to 2017, Dr. Chun was executive VP at the Kavli Foundation where she managed a network of 20 world-class research institutes from the U.S., Europe, and Asia; shaped and directed a suite of interdisciplinary scientific programs around the world; and spearheaded and grew national initiatives and global projects from conception to completion including the U.S. BRAIN Initiative, the International Brain Project, The HUMAN Project, and the United Microbiome Initiative. She holds a Ph.D. in molecular genetics from Ohio State University and was a Life Sciences Research Foundation post-doctoral fellow at the MIT Whitehead Institute for Biomedical Research under Professor Harvey Lodish.